pharmaceutical investing InMed Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update
pharmaceutical investing InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance
pharmaceutical investing InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program
pharmaceutical investing InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial
pharmaceutical investing InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
pharmaceutical investing InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update
pharmaceutical investing InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901
Goldgroup Announces Shareholder Approval of Arrangement with Gold Resource Corporation and Results of Annual General and Special Meeting
Freegold Drills 2.08 g/t Au over 62.1 m within 102.3 m of 1.67 g/t Au in Infill Drilling at Golden Summit
Metalsource Mining Expands Silver Hill District Through Strategic Land Acquisition as Exploration Footprint Continues to Grow
